Purple Biotech (PPBT) Exchange Rate Effect (2017 - 2026)
Purple Biotech's (PPBT) quarterly Exchange Rate Effect came in at -$10000.0 in Q1 2026, up 9.09% year-on-year from -$9166.7 in Q1 2025, and down 900.0% on a QoQ basis from -$1000.0 in Q4 2025.
Purple Biotech (PPBT) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 10 years of Exchange Rate Effect data on file, last reported at -$10000.0 in Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 9.09% year-over-year to -$10000.0 in Q1 2026; TTM through Mar 2026 was $8000.0, a 161.54% increase from a year earlier, with the FY2025 full-year figure at $7000.0, up 275.0% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$10000.0, down from -$1000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for PPBT reached as high as $82000.0 in Q4 2022 and fell as low as -$147000.0 in Q2 2022.
- Historically, Exchange Rate Effect has averaged -$6625.0 across 5 years, with a median of -$7500.0 in 2024.
- Across the five-year window, Exchange Rate Effect tumbled 5600.0% in 2022 and surged 800.0% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at $82000.0 in 2022, then plunged by 42.68% to $47000.0 in 2023, then slumped by 93.62% to $3000.0 in 2024, then sank by 133.33% to -$1000.0 in 2025, then plunged by 900.0% to -$10000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$10000.0 in Q1 2026, -$1000.0 in Q4 2025, and -$16000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - | -10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | -16,000.00 |
| Sep 30, 2025 | -16,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Mar 31, 2025 | -11,000.00 |
| Mar 31, 2025 | -11,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Sep 30, 2023 | -20,000.00 |